S Aronoff

1.6k total citations · 1 hit paper
6 papers, 643 citations indexed

About

S Aronoff is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, S Aronoff has authored 6 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in S Aronoff's work include Diabetes Treatment and Management (3 papers), Ion Transport and Channel Regulation (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). S Aronoff is often cited by papers focused on Diabetes Treatment and Management (3 papers), Ion Transport and Channel Regulation (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). S Aronoff collaborates with scholars based in United States, Netherlands and Poland. S Aronoff's co-authors include Susan S. Braithwaite, Sidney Rosenblatt, Annette Mathisen, J. Egan, Roger H. Unger, I Klimeś, D. M. Mott, M. Nagulesparan, Norman B. Rushforth and Gilbert M. Eisner and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Nephrology Dialysis Transplantation.

In The Last Decade

S Aronoff

6 papers receiving 598 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

2000 522 citations S Aronoff, Sidney Rosenblatt et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Aronoff United States	6	392	345	118	100	79	6	643
David Brady United States	7	233 0.6×	147 0.4×	147 1.2×	127 1.3×	31 0.4×	11	488
Russell Esterline United States	15	282 0.7×	214 0.6×	153 1.3×	94 0.9×	59 0.7×	26	589
Jo Dole United States	5	673 1.7×	613 1.8×	141 1.2×	118 1.2×	87 1.1×	5	962
G Di Maro Italy	10	180 0.5×	159 0.5×	48 0.4×	173 1.7×	55 0.7×	12	577
Elena Zinßius Germany	6	279 0.7×	212 0.6×	135 1.1×	138 1.4×	50 0.6×	7	596
Gian Paolo Fra Italy	7	375 1.0×	189 0.5×	138 1.2×	97 1.0×	61 0.8×	13	660
N. Bradly Glazer United States	7	435 1.1×	295 0.9×	128 1.1×	51 0.5×	41 0.5×	7	580
Farshad Kajbaf France	14	475 1.2×	398 1.2×	165 1.4×	91 0.9×	44 0.6×	24	801
P. Weisweiler Germany	16	375 1.0×	169 0.5×	338 2.9×	110 1.1×	48 0.6×	59	702
Aldo Soro Italy	9	354 0.9×	146 0.4×	200 1.7×	78 0.8×	55 0.7×	14	638

Countries citing papers authored by S Aronoff

Since Specialization

Citations

This map shows the geographic impact of S Aronoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Aronoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Aronoff more than expected).

Fields of papers citing papers by S Aronoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Aronoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Aronoff. The network helps show where S Aronoff may publish in the future.

Co-authorship network of co-authors of S Aronoff

This figure shows the co-authorship network connecting the top 25 collaborators of S Aronoff. A scholar is included among the top collaborators of S Aronoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Aronoff. S Aronoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Heerspink, Hiddo J.L., Tom Greene, Julia B. Lewis, et al.. (2007). Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. Nephrology Dialysis Transplantation. 23(6). 1946–1954. 44 indexed citations

2.

Aronoff, S, et al.. (2000). Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.. Diabetes Care. 23(11). 1605–1611. 522 indexed citations breakdown →

3.

Aronoff, S, et al.. (1994). Use of a premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens.. PubMed. 16(1). 41–9. 5 indexed citations

4.

Klimeś, I, M. Nagulesparan, Roger H. Unger, S Aronoff, & D. M. Mott. (1982). Reduced Na⁺,K⁺-ATPase Activity in Intact Red Cells and Isolated Membranes from Obese Man*. The Journal of Clinical Endocrinology & Metabolism. 54(4). 721–724. 46 indexed citations

5.

Aronoff, S, Peter H. Bennett, Norman B. Rushforth, Max Miller, & Roger H. Unger. (1976). Normal Glucagon Response to Arginine Infusion in “Prediabetic” Pima Indians. The Journal of Clinical Endocrinology & Metabolism. 43(2). 279–286. 13 indexed citations

6.

Aronoff, S, et al.. (1973). Effect of increased distal bicarbonate delivery on free water reabsorption in the dog. American Journal of Physiology-Legacy Content. 224(1). 209–218. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact